Figure 5From: Active RHOA favors retention of human hematopoietic stem/progenitor cells in their nicheLong term repopulation of RHOA modified HSPC. (A) Percentage of human engraftment in Control, RHOAV14 and RHOAN19 expressing HSPCs, 12 weeks post-transplantation in immuno-deficient mice. Values are means ± SEM, n = 3. (B) Percentage of Human CD34 expression in Control, RHOAV14, RHOAN19 HSPCs 12 weeks post-transplantation. The percentage of CD34 expression was normalized to the percentage of engraftment. Each dot in the graph represents individual mouse and the bar represents the median value.Back to article page